0001213900-19-016453.txt : 20190821
0001213900-19-016453.hdr.sgml : 20190821
20190821163304
ACCESSION NUMBER: 0001213900-19-016453
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190820
FILED AS OF DATE: 20190821
DATE AS OF CHANGE: 20190821
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tesi Raymond Joseph
CENTRAL INDEX KEY: 0001767280
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38793
FILM NUMBER: 191043373
MAIL ADDRESS:
STREET 1: 476 MASSACHUSETTS AVE, UNIT 2
CITY: BOSTON
STATE: MA
ZIP: 02118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inmune Bio, Inc.
CENTRAL INDEX KEY: 0001711754
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475205835
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1200 PROSPECT STREET
STREET 2: SUITE 525
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 8589643720
MAIL ADDRESS:
STREET 1: 1200 PROSPECT STREET
STREET 2: SUITE 525
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
ownership.xml
X0306
4
2019-08-20
0
0001711754
Inmune Bio, Inc.
INMB
0001767280
Tesi Raymond Joseph
C/O INMUNE BIO INC.,
1200 PROSPECT STREET, SUITE 525
LA JOLLA
CA
92037
1
1
1
0
President & CEO
Common Stock
2019-08-20
4
P
0
100
5.96
A
1539033
D
Common Stock
2019-08-20
4
P
0
100
5.96
A
1539133
D
Common Stock
2019-08-20
4
P
0
100
5.96
A
1539233
D
Common Stock
2019-08-20
4
P
0
100
5.96
A
1539333
D
Common Stock
2019-08-20
4
P
0
100
5.96
A
1539433
D
Common Stock
2019-08-20
4
P
0
100
5.96
A
1539533
D
Common Stock
2019-08-20
4
P
0
100
5.96
A
1539633
D
Common Stock
2019-08-20
4
P
0
100
5.96
A
1539733
D
Common Stock
2019-08-20
4
P
0
100
5.96
A
1539833
D
Common Stock
2019-08-20
4
P
0
100
5.9239
A
1539933
D
Common Stock
2019-08-20
4
P
0
1000
6.0308
A
1540933
D
The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 20, 2019 in eleven open market transactions.
/s/ Raymond Joseph Tesi
2019-08-21